Intramuscular glutathione as a systemic whitening agent
- Conditions
- Skin and Connective Tissue Diseases
- Registration Number
- PACTR201907742980888
- Lead Sponsor
- Sohag University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 30
Healthy female aged between 18 to 50 years old fitzpatric skin type III and V.
Personal or family history of skin cancer, especially melanoma.
Consumption of any preparations containing glutathione within 1month of enrollment.
Pigmentary disorders or any dermatoses, which may affect the measurement within the study areas.
Known hypersensitivity to glutathione.
Current pregnancy and lactation.
Current use of oral contraceptive pills or current receipt of hormone replacement therapy.
Regular participation in vigorous activities (e.g. sports) that includes exercise; occupational or leisure activities that involve daily sun exposure between 10.00 hours and 15.00 hours
A history of autoimmune disease, or immunodeficiency.
Major surgery, active or recent systemic infection within the previous four weeks.
History of liver diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method